-+ 0.00%
-+ 0.00%
-+ 0.00%

PARABILIS MEDICINES - REPORTS 72.2% OBJECTIVE RESPONSE RATE AT 32 WEEKS FOR STARTING DOSE ≥450 MG

Reuters·10/24/2026 12:45:48

Please log in to view news